Apyx Medical Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +33.3% | -10.8% | -7.5% | -7.1% | +6.8% | -7.2% | -3.3% | -1.4% | +16.5% | -5.7% | -3.1% | |
| – | +40.3% | -12.0% | -8.5% | -8.0% | +8.2% | -8.1% | -3.7% | -2.3% | +19.8% | -6.3% | -3.0% | |
| – | +97.2% | -14.6% | -12.3% | -14.3% | +13.3% | -2.3% | -5.5% | -14.2% | +26.3% | -1.9% | -11.3% | |
| – | +97.2% | -14.6% | -12.3% | -14.3% | +13.3% | -2.3% | -5.5% | -14.2% | +26.3% | -1.9% | -11.3% | |
| – | +5.9% | -11.0% | +1.8% | +2.6% | +18.7% | -24.8% | -3.4% | +15.5% | +29.1% | -24.0% | +6.7% | |
| – | -12.1% | -1.3% | -4.8% | -3.5% | -16.0% | +1.6% | +6.6% | +11.6% | -5.9% | +10.9% | +12.7% | |
| – | +102.3% | -4.0% | +0.4% | -1.9% | +2.0% | -2.0% | +2.5% | +1.1% | +1.4% | -4.0% | +0.1% | |
| – | +23.8% | -17.1% | +0.8% | -10.2% | +12.2% | -11.3% | +11.1% | +3.9% | +6.6% | -19.3% | -1.0% | |
| – | +11.2% | +2.5% | -11.4% | +5.1% | +1.4% | +5.4% | +6.4% | +4.0% | +3.4% | +3.0% | +7.0% | |
| – | +32.3% | -22.5% | +11.7% | -18.5% | +36.6% | -11.9% | +25.5% | +11.3% | -5.0% | -14.0% | -16.7% | |
| – | +268.4% | +0.7% | +0.7% | +0.7% | +0.1% | +0.7% | +0.7% | +0.7% | +0.7% | +0.7% | +0.7% | |
| – | -19.9% | -24.1% | -27.2% | -25.1% | +28.7% | -26.0% | -31.0% | -19.4% | +148.6% | -11.7% | -16.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +10.3% | -7.0% | +14.6% | +0.0% | +3.5% | +0.0% | +0.0% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.